| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Normal phase POSITIVE ION MODE | GOLPH3_OE_1 | Treatment:GOLPH3 overexpression | pmol |
| Normal phase POSITIVE ION MODE | GOLPH3_OE_2 | Treatment:GOLPH3 overexpression | pmol |
| Normal phase POSITIVE ION MODE | GOLPH3_OE_3 | Treatment:GOLPH3 overexpression | pmol |
| Normal phase POSITIVE ION MODE | GOLPH3_KD_1 | Treatment:GOLPH3 silencing | pmol |
| Normal phase POSITIVE ION MODE | GOLPH3_KD_2 | Treatment:GOLPH3 silencing | pmol |
| Normal phase POSITIVE ION MODE | GOLPH3_KD_3 | Treatment:GOLPH3 silencing | pmol |
| Normal phase POSITIVE ION MODE | CTRL_1 | Treatment:no treatment | pmol |
| Normal phase POSITIVE ION MODE | CTRL_2 | Treatment:no treatment | pmol |
| Normal phase POSITIVE ION MODE | CTRL_3 | Treatment:no treatment | pmol |
Return to study ST001672 main page
Download data matrix(Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 (part-I) Normal phase POSITIVE ION MODE)
- Metabolomics Workbench
|